A method for preparing carbon-platinum hollow spheres using Haematococcus pluvialis as a reducing template
A technology of Haematococcus pluvialis and hollow spheres is applied in catalyst activation/preparation, chemical instruments and methods, physical/chemical process catalysts, etc., and can solve the problems of strict and complicated preparation method of platinum particles, difficult particle size control, etc., Achieve uniform size, huge specific surface area, and solve strict and complex effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0015] Specific embodiment one: A kind of method of preparing carboplatin hollow spheres with Haematococcus pluvialls as reducing template in this embodiment is carried out according to the following steps:
[0016] (1) Fixation of Haematococcus pluvialis: Collect Haematococcus pluvialls in the culture medium by filtration under reduced pressure, wash with distilled water and absolute ethanol under reduced pressure for 1-5 minutes, and then add to formaldehyde Soak in forest solution for 10 to 120 minutes, filter under reduced pressure and wash with distilled water under reduced pressure for 1 to 5 minutes to complete the fixation and purification of Haematococcus pluvialls, wherein the Haematococcus pluvialls used is red aflagellate quiescent cells;
[0017] (2) Preparation of platinum plating solution: add 5.0~25.0 g / L gluconic acid into a mixed solvent composed of deionized water and acetone, adjust the pH value to 8.0~12.0 with ammonia water, then add 0.1~5.0 g / L Platinum ...
specific Embodiment approach 2
[0021] Embodiment 2: The difference between this embodiment and Embodiment 1 is that the volume percentage of acetone in the mixed solvent described in step (2) is 5-30%. Others are the same as in the first embodiment.
specific Embodiment approach 3
[0022] Specific embodiment three: the difference between this embodiment and specific embodiment one or two is that the platinum salt described in step (2) is tetraammine platinum chloride, tetraammine platinum nitrate, ammonium chloroplatinite or platinum chloride A kind of potassium acid. Others are the same as in the first or second embodiment.
[0023] Verify beneficial effect of the present invention with following test:
PUM
| Property | Measurement | Unit |
|---|---|---|
| percent by volume | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 

